Other Auxiliary Agent

Shah Glenn Dean is a treatment for type 2 diabetes, which stimulates the pancreas to produce more insulin after meals. It is a dipeptidyl peptidase-4 (DPP-IV) inhibitor jointly developed by AstraZeneca and Bristol Myers Squibb. In July 31, 2009, Shack Leo Dean and Onglyza, a new type 2 diabetes mellitus developed jointly by AstraZeneca and Bristol Myers Squibb, were approved by the US FDA to treat adults with type 2 diabetes once a day, while controlling diet and strengthening exercise. The most common side effects are upper respiratory tract infection, urinary tract infection and headache. Other side effects include allergic reactions such as rash and urticaria.

Calcium phytate is widely used. In the food industry, after being hot pressed and sterilized with 0.1% calcium phytate solution, the cover can be prevented from rust. Therefore, it can be used as corrosion inhibitor, as well as as as processing agent for brewing water, metal remover for products such as wine and vinegar. In the fermentation industry, potassium phosphate can be replaced in the culture of alcoholic yeast, which makes yeast proliferate, ethanol increases and tastes more fragrant. It is easy to electroplate after being treated with calcium phytate solution on the metal surface. In the field of medicine, calcium phytate, as a nutrient, can promote metabolism, increase appetite and nutrition, and promote development. It is suitable for treating various diseases of the nervous system, as well as vascular hypothyroidism, hysteria, neurasthenia, rickets, rickets, anemia, tuberculosis and so on. Calcium magnesium phytate is also used to enrich micro niobium.

Inosine isopropyl is an immunomodulatory drug. In vitro experiments show that it can enhance the immune response of PHA or antigen, promote the differentiation and proliferation of T lymphocytes, and stimulate the differentiation and production of antibodies of B lymphocytes by activating Th cells or macrophages.

4-chloropyrrolopyrimidine is an important pharmaceutical intermediate, which is used as an intermediate for the bulk drug of tofacinib in the treatment of adult patients with moderate to severe rheumatoid arthritis, such as methotrexate underreaction or intolerance. 4-chloropyrrolopyrimidine is also an important raw material for the development of many antibacterial, anti-tumor, anti vertebral worms and other drugs.